How to buy IQVIA (IQV) shares in Australia
Learn how to easily invest in IQVIA shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
IQVIA Holdings Inc (IQV) is a leading diagnostics & research business with stocks listed in the US. It opened the day at US$248.92 after a previous close of US$248.71. During the day the price has varied from a low of USD247.2 to a high of USD249.91. The latest price was USD247.7 (25 minute delay). IQVIA is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in IQVIA
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for IQVIA. Find the share by name or ticker symbol: IQV. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until IQVIA reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$248.71, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of IQVIA, depending on your broker.
- Check in on your investment. Congratulations, you own a part of IQVIA. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
IQVIA stock price (NYSE:IQV)Use our graph to track the performance of IQV stocks over time.
IQVIA shares at a glance
|52-week range||US$170 - US$285.61|
|50-day moving average||US$264.598|
|200-day moving average||US$248.5576|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$3.929|
Where to buy IQVIA stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy IQVIA stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
IQVIA price performance over time
|1 week (2022-01-10)||-3.70%|
|1 month (2021-12-17)||-7.38%|
|3 months (2021-10-15)||-0.46%|
|6 months (2021-07-17)||0.49%|
|1 year (2021-01-15)||31.90%|
|2 years (2020-01-16)||53.88%|
|3 years (2019-01-16)||98.57%|
|5 years (2017-01-13)||221.02%|
Stocks similar to IQVIA
Is IQVIA under- or over-valued?
Valuing IQVIA stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IQVIA's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
IQVIA's P/E ratio
IQVIA's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 63x. In other words, IQVIA shares trade at around 63x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
IQVIA's PEG ratio
IQVIA's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0379. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into IQVIA's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
IQVIA's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$2.3 billion (£1.7 billion).
The EBITDA is a measure of a IQVIA's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||US$13.5 billion|
|Operating margin TTM||9.33%|
|Gross profit TTM||US$3.9 billion|
|Return on assets TTM||3.3%|
|Return on equity TTM||13.12%|
|Market capitalisation||US$47.3 billion|
TTM: trailing 12 months
IQVIA's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like IQVIA.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
IQVIA's total ESG risk score
Total ESG risk: 26.81
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and IQVIA's overall score of 26.81 (as at 12/31/2018) is pretty good – landing it in it in the 37th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like IQVIA is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
IQVIA's environmental score
Environmental score: 1.17/100
IQVIA's environmental score of 1.17 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that IQVIA is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
IQVIA's social score
Social score: 14.76/100
IQVIA's social score of 14.76 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that IQVIA is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
IQVIA's governance score
Governance score: 6.88/100
IQVIA's governance score puts it squarely in the 3rd percentile of companies rated in the same sector. That could suggest that IQVIA is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
IQVIA's controversy score
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. IQVIA scored a 1 out of 5 for controversy – the highest score possible, reflecting that IQVIA has managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||26.81|
|Total ESG percentile||36.72|
|Environmental score percentile||3|
|Social score percentile||3|
|Governance score percentile||3|
|Level of controversy||1|
IQVIA share dividends
We're not expecting IQVIA to pay a dividend over the next 12 months.
IQVIA share price volatility
Over the last 12 months, IQVIA's shares have ranged in value from as little as US$170 up to US$285.61. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while IQVIA's is 1.4075. This would suggest that IQVIA's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. IQVIA has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
IQVIA in the news
IQVIA Holdings (IQV) Shares Cross Below 200 DMA
Vaughan Nelson Investment Management, L.p. ...
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Frequently asked questions
More guides on Finder
Interview: RAQ founder talks Abbie Chatfield swim collection
RAQ Apparel founder Sophia Argyropoulos chats the inspo for Abbie Chatfield swimwear collab and the secret to finding the perfect bikini.
7 ways to elevate your home movie experience [SPONSORED] Turn your low-key movie nights into a main attraction that can keep everyone entertained.
American Express Qantas Corporate Gold Card
With a 100,000 bonus Membership Rewards offer and complimentary Qantas Business Rewards membership, is this the right card for your business?
How to watch Liverpool vs Arsenal Carabao Cup live and free in Australia
Liverpool and Arsenal battle for a place in the League Cup final.
Rapid antigen tests: When will RAT stock be available? [UPDATED]
Rapid antigen tests are proving extremely hard to find, but there are options if you can be patient trying to find a RAT.
New on Netflix, Prime Video, Disney Plus, Stan, Foxtel, BINGE and more in January 2022
You can easily elevate your binge-watching game in the New Year.
Where to watch DC series Peacemaker online in Australia
He believes in peace at any cost – no matter how many people he has to kill to get it.
How to watch Melbourne Renegades vs Melbourne Stars BBL live and match preview
Both Melbourne teams are fighting for their seasons as we embark on derby number 2
10 beauty trends that’ll pop off in 2022
From clean beauty to bedazzled everything, these are the makeup looks will take over 2022 and the products you need to pull them off.
Compare rapid antigen test brands: How do they stack up?
Not all tests are created equal here are the different brands compared.
Ask an Expert